Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake

The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week that target the latest versions of the omicron variant but will do so without data from a study showing the shots were safe and worked in humans.